Treatment of esophagogastric varices

Endoscopy

Volumn 28, Issue 1, 1996, Pages 44-53

  Binmoeller, K F ^a   Sy, P ^a   Soehendra, N ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYANOACRYLATE; ENBUCRILATE; MONOETHANOLAMINE OLEATE; OCTREOTIDE; SOMATOSTATIN; TERLIPRESSIN; TETRADECYL SULFATE SODIUM; VASOPRESSIN;

BACTERIAL INFECTION; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; HUMAN; LIGATION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; STOMACH VARICES;

EID: 0029926804     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1005417     Document Type: Review

References (82)

1. Chan A, Chung NS, Sung JY, et al.: A double-blind randomized controlled trial comparing sodium tetradecyl sulphate and ethanolamine oleate in the sclerotherapy of bleeding oesophageal varices. Endoscopy 1993; 25: 513-517.
2. Moreto M, Zaballa M, Ojembarrena E, et al.: Combined (short-term plus long-term) sclerotherapy vs. short-term only scterotherapy: a randomised prospective trial. Gut 1994; 35: 687-691.
3. McKee RF, Garden OJ, Anderson JR, Carter DC: A trial of elective versus on-demand sclerotherapy in "poor-risk" patients with variceal haemorrhage. Endoscopy 1994; 26: 474-477.
4. The Veterans' Affairs Cooperative Variceal Sclerotherapy Group: Sclerotherapy for male alcoholic cirhotic patients who have bled from esophageal varices: results of a randomized, multicenter clinical trial. Hepatology 1994; 20: 618-625.
5. Selby WS, Norton ID, Pokorny CS, Benn R: Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomized trial. Gastrointest Endosc 1994; 40: 680-684.
6. Blaise M, Pateron D, Trinchet JC, et al.: Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1994; 20: 34-38.
7. Paquet KJ, Kalk JF, Klein CP, Gad HA: Prophylactic sclerotherapy for esophageal varices in high-risk cirrhotic patients selected by endoscopic and hemodynamic criteria: a randomized, single-center controlled trial. Endoscopy 1994; 26: 734-740.
8. Koch H, Binmoeller KF, Grimm H, et al.: Prophylactic sclerotherapy for esophageal varices: long-term results of a prospective study. Endoscopy 1994; 26: 729-733.
9. Pötzi R, Bauer P, Schofl R, et al.: Prophylactic endoscopic sclerotherapy of esophageal varices in liver cirrhosis: long-term follow-up and final results of a multicenter prospective controlled randomized trial in Vienna. Endoscopy 1993; 25: 287-289.
10. Fardy JM, Laupacis A: A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices. Am J Gastroenterol 1994; 89: 1938-1948.
11. Stiegmann GV, Goff JS, Michaletz OP, et al.: Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992; 326: 1527-1532.
12. Gimson A, Ramage JK, Panos MZ, et al.: Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet 1993; 342: 391-394.
13. Young MF, Sanowski RA, Rasche R: Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest Endosc 1993; 39: 119-122.
14. Hashizume M, Ohta M, Ueno K, et al.: Endoscopic ligation of esophageal varices compared with injection sclerotherapy: a prospective randomized trial. Gastrointest Endosc 1993; 39: 123-126.
15. Laine L, Cook D: Endoscopic ligation vs. sclerotherapy for esophageal variceal bleeding: a meta-analysis. Gastroint Endosc 1994; 40: P77.
16. Marks RD, Arnold MD, Baron TH: Gross and microscopic findings in the human esophagus after esophageal variceal band ligation: a postmortem analysis. Am J Gastroenterol 1993; 88: 272-274.
17. Evans DM, Jones DB, Cleary BK, Smith PM: Oesophageal varices treated by sclerotherapy: a histopathological study. Gut 1982; 23: 615-620.
18. Tseng CC, Green RM, Burke SK, et al.: Bacteremia after endoscopic band ligation of esophageal varices. Gastrointest Endosc 1992; 38: 336-337.
19. Lo GH, Lai KH, Shen MT, Chang CF: A comparison of the incidence of transient bacteremia and infectious sequelae after sclerotherapy and rubber band ligation of bleeding esophageal varices. Gastrointest Endosc 1994; 40: 675-679.
20. Berner JS, Going AA, Sharma R, et al.: Sequelae after esophageal variceal ligation and sclerotherapy: a prospective randomized study. Am J Gastroenterol 1994; 89: 852-857.
21. Berkelhammer C, Madhav G, Lyon S, Roberts J: "Pinch" injury during overtube placement in upper endoscopy. Gastrointest Endosc 1993; 39: 186-188.
22. Golkel H, Frohlich E: A severe complication of endoscopic band ligation of esophageal varices. Leber Magen Darm 1994; 24: 77-78.
23. Minoli G: Esophageal perforation and variceal banding. Endoscopy 1994; 26: 633.
24. Goldschmiedt M, Haber G, Kandel G, et al.: A safety maneuver for placing overtubes during endoscopic variceal ligation Gastrointest Endosc 1992; 38: 399-400.
25. Saltzman JR, Arora S: Complications of esophageal variceal band ligation. Gastrointest Endosc 1993; 39: 185-186.
26. Johnson PA, Campbell DR, Antonson CW, et al.: Complications associated with endoscopic band ligation of esophageal varices. Gastrointest Endosc 1993; 39: 181-185.
27. Sakai P, Malaf FF, Melo JM, Ishioka S: Is endoscopic band ligation of esophageal varices contraindicated in Child-Pugh C patients? Endoscopy 1994; 26: 511-512.
28. Schoonbroodt D, Zipf A, Jung M: Local necrosis and fatal perforation of oesophagus after endoscopic ligation [letter]. Lancet 1994; 344: 1365.
29. Hou MC, Lin HC, Chang FY, et al.: Oesophageal perforation following endoscopic variceal ligation and balloon tamponade. J Gastroenterol Hepatol 1994; 9: 659-662.
30. ASGE Technology Assessment Committee: Endoscopic band ligation of vances. Gastrointest Endosc 1993; 39: 877.
31. De Franchis R, et al.: Baveno II: 2nd International Consensus Workshop: definitions, methodology and therapeutic strategies in portal hypertension. Baveno, Italy: April, 1995.
32. Gotlib JP, Zimmermann P: Une nouvelle technique de traitement endoscopique des varices oesophagiennes: l'obliteration. Endosc Dig 1984; 7: 10-12.
33. Ramond MJ, Valla D, Gotlib JP, et al.: Endoscopic obliteration of esophagogastric varices with bucrylate, 1: clinical study in 49 patients. Gastroenterol Clin Biol 1986; 10: 8-9.
34. Feretis C, Tabakopoulos D, Benalds P, et al.: Endoscopic hemostasis of esophageal and gastric variceal bleeding with Histoacryl. Endoscopy 1990; 22: 282-284.
35. Rauws EAJ, Jansen PLM, Tytgat GNJ: Endoscopic sclerotherapy of gastric varices with bucrylate: treatment of acute bleeding and long-term follow-up [abstract]. Gastrointest Endosc 1991; 37: A242.
36. Moustafa I, Omar MM, Nooh A: Endoscopic control of gastric variceal bleeding with butyl cyanoacrylate [abstract]. Endoscopy 1993; 25: A11.
37. Pretis G, De CM, Guelmi A, et al.: N-butylcyanoacrylate (C) in bleeding oesophageal (EBV) and gastric (GBV) varices: experience in 135 cirrhotic patients [abstract]. Endoscopy 1993; 25: A14.
38. Dal Monte PP, Baroncini D, Piemontese A, et al.: N-Butyl-2-cyanoacrylate in the endoscopic treatment of upper GI varices. 1994; 26: 401.
39. Thakeb F, Salama Z, Salama H, et al.: The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric vances. Endoscopy 1995; 27: 358-364.
40. Feretis C, Dimopoulus C, Benakis P, et al.: N-Buryl-2-cyanoacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study. Endoscopy 1995; 27: 355-357.
41. Soderlund C, Ihre T: Endoscopic sclerotherapy vs. conservative management of bleeding oesophageal varices: a 5-year prospective controlled trial of emergency and long-term treatment. Acta Chir Scand 1985; 151: 449-456.
42. Trudeau W, Prindiville T: Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986; 32: 264-268.
43. Yassin ZM, Eita MS, Hussein A: Endoscopic sclerotherapy for bleeding gastric vances [abstract]. Gut 1985; 26: A1105.
44. Watanabe K, Kimura K, Matsutani S: Portal hemodynamics in patients with gastric varices. Gastroenterology 1988; 95: 434-440.
45. Oho K, Iwao T, Sumino M, et al.: Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 1995; 27: 349-354.
46. Williams SGJ, Peters RA, Westaby D: Thrombin: an effective treatment for gastric variceal hemorrhage. Gut 1994; 35: 1287 -1289.
47. Stiegmann GV: Elastic band ligation of esophageal and gastric varices. New York: Raven Press, 1994: 95-103.
48. Yoshida T, Hayashi N, Suzumi N, et al.: Endoscopic ligation of gastric varices using a detachable snare. Endoscopy 1994; 26: 502-505.
49. Jutabha R, Jensen DM, Egan J, et al.: Randomized, prospective study of cyanoacrylate injection, sclerotherapy, or rubber band ligation for endoscopic hemostasis of bleeding canine gastric varices. Gastrointest Endosc 1995; 41: 201-205.
50. Jutabha R, Jensen DM, See J, et al.: Randomized, controlled study of various agents for endoscopic injection sclerotherapy of bleeding canine gastric varices. Gastrointest Endosc 1995; 41: 206-211.
51. Simpson KJ, Chalmers N, Redhead DN, et al.: Transjugular intrahepatic portasystemic stem shunting for control of acute and recurrent upper gastrointestinal haemorrhage related to portal hypertension. Gut 1993; 34: 968-973.
52. Rössle M, Haag K, Ochs A, et al.: The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-171.
53. Haskal ZJ, Pentecost MJ, Soulen MC, et al.: Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results. Am J Roentgenol 1994; 163: 439-444.
54. Nazarian GK, Ferrai H, Castaneda ZW, et al.: Development of stenoses in transjugular intrahepatic portosystemic shunts. Radiology 1994; 192: 231-234.
55. Lind CD, Malisch TW, Chong WK, et al.: Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 1994; 106: 1277-1283.
56. McCormick PA, Dick R, Panagou EB, et al.: Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg 1994; 81: 1324-1327.
57. Sanyal AJ, Freedman AM, Shiffman ML, et al.: Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20: 46-55.
58. LaBerge JM, Somberg KA, Lake JR, et al.: Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108: 1143-1151.
59. [GI]Sellinger M, Ochs S, Haag K, et al.: Incidence of hepatic encephalopathy and follow-up of liver function in patients with transjugular intrahepatic portosystemic stent-shunt (TIPS) [abstract]. Hepatology 1992; 102: A883.
60. Blei AT: Hepatic encephalopathy in the age of TIPS. Hepatology 1994; 20: 249-252.
61. LaBerge JM, Ring EJ, Gordon RL, et al.: Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radioiogy 1993; 187: 413-420.
62. Helton WS, Belshaw A, Althaus S, et al.: Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 1993; 165: 566-571.
63. Simpson KJ, Chalmers N, Redhead DN, et al.: Emergency transjugular intrahepatic portosystemic stent shunts to control acute variceal haemorrhage resistant to sclerotherapy. Eur J Gastroenterol Hepatol 1994; 6: 423-428.
64. Sanyal AJ, Freedman AM, Shiffman ML: Transjugular intrahepatic portosystemic shunt for ascites: a preliminary report [abstract]. Am J Gastroenterol 1992; 87: A1305.
65. Soderlund C, Magnusson I, Torngren S, Lundell L: Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 1990; 25: 622-630.
66. Fort E, Sautereau D, Silvain C, et al.: A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage. Hepatology 1990; 11: 678-681.
67. Freeman JG, Cobden I, Record C: Placebo-controlled trial of terlipressin (Glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol 1989; 11: 58-60.
68. D'Amico G, Trama M, Vizzini G, et al.: Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis: a randomized clinical trial. J Hepatol 1994; 20: 206-212.
69. Kravetz D, Bosch J, Teres J, et al.: Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology 1984; 4: 442-446.
70. Walker S, Stiehl A, Raedshc R, Kommerell B: Terlipressin in bleeding esophageal varices: a placebo-control led, double-blind study. Hepatology 1986; 6: 112-115.
71. Silvain C, Carpentier S, Sautereau D, et al.: Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 1993; 18: 61-65.
72. Jenkins SA, Baxter JN, Corbett W, et al.: A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J 1985; 290: 275-278.
73. Bagarani M, Albenini V, Anza M, et al.: Effect of somatostatin in controlling bleeding from esophageal varices. Ital J Surg Sci 1987; 17: 21-26.
74. Saari A, Kivilaakso E, Inberg M, et al.: Comparison of somatostatin and vasopressin in bleeding esophageal varices. Am J Gastroenterol 1990; 85: 804-807.
75. Huang CC, Shen IS, Chu CM, et al., A prospective randomized controlled trial of sandostatin and vasopressin in the management of acute bleeding esophageal varices. Chang Gung Med J 1992; 15: 78-83.
76. McKee R: Sandostatin therapy of acute oesophageal variceal bleeding. Digestion 1993; 54 (suppl 1): 27-29.
77. Sung J, Chung S, Lai CW, et al.: Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 1993; 342: 637-641.
78. Burroughs AK, McCormick RA, Hughes MD, et al.: Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding: emergency control and prevention of early variceal rebleeding. Gastroenterology 1990; 99: 1388-1395.
79. Valenzuela JE, Schubert T, Fogel MR, et al.: A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology 1989; 10: 958-961.
80. Avgerinos A, Rekoumis G, Klonis C, et al.: Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy: a randomized controlled trial. J Hepatol 1993; 19: 301-311.
81. Bertoni G, Sassatelli R, Fornaciari G, et al.: Oral isosorbide-5-mononitrate reduces the rebleeding rate during the course of injection sclerotherapy for esophageal varices. Scand J Gastroenterol 1994; 29: 363-370.
82. Zimmon DS: Endoscopic esophagogastric balloon tamponade. Gastrointest Endosc 1994; 40: 734-740.